Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HEMGN | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
mRNA | ZNF532 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
mRNA | ADAMTS10 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
mRNA | COA6 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
mRNA | RP11-463D19.2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
mRNA | CAPN7 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
mRNA | MED23 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
mRNA | AC138969.4 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
mRNA | FHL3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
mRNA | FAM72C | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0008 |